Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 601 to 610 of 1904

TitleReference numberPublishedLast updated
Atezolizumab monotherapy for untreated advanced non-small-cell lung cancerTA705
Ibrutinib with obinutuzumab for untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (terminated appraisal)TA702
Ibrutinib with rituximab for untreated chronic lymphocytic leukaemia (terminated appraisal)TA703
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 2 or more anti-HER2 therapiesTA704
Electrohydraulic lithotripsy for difficult-to-treat bile duct stonesIPG698
Ex-situ machine perfusion for extracorporeal preservation of lungs (ex-vivo lung perfusion) for transplantIPG695
Transvaginal laser therapy for stress urinary incontinenceIPG696
Transvaginal laser therapy for urogenital atrophyIPG697
Heavy menstrual bleeding: assessment and managementNG88
Ravulizumab for treating paroxysmal nocturnal haemoglobinuriaTA698

Results per page

  1. 10
  2. 25
  3. 50
  4. All